SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aviron
AVIR 3.375+1.7%Nov 11 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SG who wrote (172)11/1/1997 7:49:00 AM
From: Haolin Ni  Read Replies (1) of 645
 
Pls read all my posts. This company is not good one for you looking for a kill. You may be killed by it. Now there are so many cheap stocks available and stick to AVIR is definitely not good choice. The FDA approval is about two years away. You could certainly buy it under $20 even under $15 if you set a order good untill cancelled.

You must know flu vaccine could not have a earning explosion but any good tech company could. Therefore, you should looking for a kill from the tech company instead of a biotech company. Even within the biotech company, a lot of the biotech stocks are better than AVIR, a single products company known have limited earning in the future even if it could be approval by FDA.

Good luck!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext